Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_assertion description "[However, the addition of ABT-737 to either a vaccine strategy involving priming with TRP-2 melanoma antigen peptide-pulsed DC and boosting with recombinant Listeria monocytogenes expressing the same melanoma antigen, or the adoptive transfer of TCR transgenic cells, did not result in superior antitumor activity against B16 murine melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_assertion evidence source_evidence_literature NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_assertion SIO_000772 18807035 NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_assertion wasDerivedFrom befree-20140225 NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_assertion wasGeneratedBy ECO_0000203 NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP207395.RAZQyJ3QgOQfOW-AJoim-1raJfFotogghqXIBHAtvXSU4130_provenance.